日本調剤(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 小売業 | 3341/E05422 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2017/02/24 | 日証協 | 621,344株 | +8.49% | 136,190株 | +7.32% | 704,853株 | +0.11% | 388,296株 | -11.57% |
2017/02/17 | 日証協 | 572,727株 | +16.81% | 126,904株 | +34.57% | 704,071株 | +16.2% | 439,109株 | -37.45% |
2017/02/10 | 日証協 | 490,323株 | +10.75% | 94,300株 | +464.33% | 605,927株 | +2.61% | 702,014株 | +3.21% |
2017/02/03 | 日証協 | 442,716株 | +0.41% | 16,710株 | -94.07% | 590,511株 | +1.58% | 680,211株 | +98.3% |
2017/01/27 | 日証協 | 440,896株 | +1.26% | 281,720株 | +1179.03% | 581,311株 | +1.38% | 343,024株 | -10.77% |
2017/01/20 | 日証協 | 435,426株 | -16.05% | 22,026株 | +38.53% | 573,411株 | -11.79% | 384,417株 | +2.89% |
2017/01/13 | 日証協 | 518,646株 | +0.76% | 15,900株 | +97.52% | 650,068株 | +4.19% | 373,618株 | +7084.96% |
2017/01/06 | 日証協 | 514,736株 | -0.14% | 8,050株 | -80.95% | 623,928株 | +0.95% | 5,200株 | -87.13% |
2016/12/30 | 日証協 | 515,436株 | -3.14% | 42,253株 | +2.46% | 618,028株 | +2.6% | 40,402株 | +1.48% |
2016/12/22 | 日証協 | 532,167株 | -3.55% | 41,237株 | -35.42% | 602,360株 | -0.57% | 39,814株 | -90.1% |
2016/12/16 | 日証協 | 551,776株 | +11.48% | 63,850株 | +150.39% | 605,826株 | +11.85% | 402,024株 | +1051.93% |
2016/12/09 | 日証協 | 494,946株 | -1.04% | 25,500株 | +242.28% | 541,646株 | -0.48% | 34,900株 | -94.77% |
2016/12/02 | 日証協 | 500,146株 | +0.44% | 7,450株 | -97.27% | 544,246株 | -1.29% | 667,408株 | +9999.99% |
2016/11/25 | 日証協 | 497,966株 | -1.16% | 273,190株 | +9999.99% | 551,346株 | -4.2% | 400株 | -90% |
2016/11/18 | 日証協 | 503,826株 | -1.58% | 530株 | -94.18% | 575,546株 | -0.5% | 4,000株 | -98.81% |
2016/11/11 | 日証協 | 511,926株 | -10.67% | 9,100株 | -83.03% | 578,446株 | -7.13% | 336,404株 | -50.98% |
2016/11/04 | 日証協 | 573,042株 | +5.59% | 53,620株 | +227.19% | 622,838株 | +6.37% | 686,306株 | +4.92% |
2016/10/28 | 日証協 | 542,698株 | -4.41% | 16,388株 | -5.27% | 585,512株 | -4.17% | 654,100株 | +109.11% |
2016/10/21 | 日証協 | 567,730株 | -4.99% | 17,300株 | +303.45% | 610,974株 | -3.88% | 312,803株 | +2.35% |
※株式分割は考慮していませんのでご注意ください。
Page Top